We are live on ! Find out more
MA

MYDA Advisors Portfolio holdings

AUM $608M
1-Year Est. Return 77.08%
This Fund
S&P 500
This Quarter Est. Return
-1.87%
1 Year Est. Return
+77.08%
3 Year Est. Return
+189.24%
5 Year Est. Return
+248.06%
10 Year Est. Return
AUM
$253M
AUM Growth
-$122M
Cap. Flow
-$109M
Cap. Flow %
-43.21%
Top 10 Hldgs %
25.22%
Holding
321
New
64
Increased
23
Reduced
53
Closed
114

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$8.72M
2
BKNG icon
Booking.com
BKNG
+$6.24M
3
FMAC
FirstMark Horizon Acquisition Corp.
FMAC
+$5.64M
4
DIS icon
Walt Disney
DIS
+$5.42M
5
PLD icon
Prologis
PLD
+$4.71M

Sector Composition

Rank Sector Weight
1 Financials 27.72%
2 Consumer Discretionary 12.42%
3 Technology 10.27%
4 Communication Services 9.32%
5 Healthcare 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATAI icon
176
AtaiBeckley Inc
ATAI
$2.66B
$61K 0.02%
+12,000
New +$66.7K
DBTX
177
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$61K 0.02%
+20,000
New +$76.6K
MKTWW
178
DELISTED
MarketWise, Inc. Warrant
MKTWW
$61K 0.02%
84,000
RKDA icon
179
Arcadia Biosciences
RKDA
$1.4M
$56K 0.02%
1,001
-1,502
-60% -$71.6K
RNWWW
180
ReNew Energy Global PLC Warrant
RNWWW
$59.3K
$55K 0.02%
31,300
BTWNW
181
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$50K 0.02%
90,000
LAAAW
182
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$46K 0.02%
131,250
PEARW
183
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$45K 0.02%
57,162
-2,838
-5% -$1.99K
NOACW
184
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
$43K 0.02%
270,360
-30,000
-10% -$7.04K
HTCR icon
185
HeartCore Enterprises
HTCR
$3.14M
$34K 0.01%
+588
New +$32.4K
MBTCR
186
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$32K 0.01%
150,000
NUVB.WS
187
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$31K 0.01%
38,000
FLACW
188
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$26K 0.01%
129,800
OPA.WS
189
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$23K 0.01%
24,000
MOBXW icon
190
Mobix Labs Warrants
MOBXW
$772K
$22K 0.01%
107,614
GRNAW
191
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$19K 0.01%
24,150
KITTW icon
192
Nauticus Robotics Warrant
KITTW
$193K
$18K 0.01%
42,550
-5,450
-11% -$2.27K
SLAMW
193
DELISTED
Slam Corp. warrant
SLAMW
$18K 0.01%
42,900
MACUW
194
DELISTED
Mallard Acquisition Corp. Warrant
MACUW
$17K 0.01%
200,000
-11,079
-5% -$1.68K
EQRXW
195
DELISTED
EQRx, Inc. Warrant
EQRXW
$16K 0.01%
18,880
CLAA.WS
196
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$16K 0.01%
40,000
TINV.WS
197
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$16K 0.01%
40,000
IMPX.WS
198
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$16K 0.01%
20,000
THCPW
199
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$15K 0.01%
23,900
TBSAW
200
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
$15K 0.01%
51,705
-7,295
-12% -$2.93K

Similar funds

MYDA Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, MYDA Advisors held 321 positions worth $253M, down 32% from $375M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MYDA Advisors withdrew a net $109M in Q1 2022, closing 114 positions and reducing 53 holdings. Its most notable exit was Oracle, an estimated $8.72M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, MYDA Advisors opened a new position in State Street SPDR S&P 500 ETF Trust worth $8.13M.

  • MYDA Advisors's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 18,000 shares worth $8.13M.
  • MYDA Advisors added most to Expedia Group in Q1 2022, an estimated $2.06M increase.
  • MYDA Advisors's biggest Q1 2022 reduction was Criteo, cutting an estimated $3.75M.
  • MYDA Advisors fully exited Oracle in Q1 2022, selling an estimated $8.72M.
  • MYDA Advisors's ten largest holdings make up 25% of its $253M portfolio in Q1 2022.
  • MYDA Advisors opened 64 new positions and closed 114 in Q1 2022.
  • MYDA Advisors's portfolio value fell 32% quarter-over-quarter to $253M.

Based on MYDA Advisors's 13F filing for Q1 2022, filed 13 May 2022.